PKP2-ACM

Clinical trials for PKP2-ACM explained in plain language.

Never miss a new study

Get alerted when new PKP2-ACM trials appear

Sign up with your email to follow new studies for PKP2-ACM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Gene therapy for rare heart disease: Long-Term safety check begins

Disease control ENROLLING_BY_INVITATION

This study follows 10 people who already received the experimental gene therapy LX2020 for a genetic heart condition called arrhythmogenic cardiomyopathy. Researchers will monitor them for years to see if the treatment remains safe and continues to work. The goal is to understand…

Matched conditions: PKP2-ACM

Sponsor: Lexeo Therapeutics • Aim: Disease control

Last updated May 12, 2026 13:43 UTC

PKP2-ACM

Get alerted when new PKP2-ACM trials appear

Gene therapy for rare heart disease: Long-Term safety check begins